Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPA2P is the transient receptor potential cation channel subfamily A member 2, pseudogene, encoded by the HGNC symbol TRPA2P and Ensembl gene ENSG00000250979. Unlike other TRP family members, TRPA2P is classified as a pseudogene and does not encode a functional channel or protein. Pseudogenes are typically genomic DNA sequences similar to known genes, but they are generally nonfunctional due to critical mutations or incomplete sequences. TRPA2P should not be considered a therapeutic target, receptor, transporter, or enzyme, and its inclusion in a target list usually represents a data annotation error or misinterpretation[2]. In summary, TRPA2P is not a therapeutic target and there is no evidence for any biological function, interacting drugs, or molecular mechanisms. If you intended to query the functional TRPA1 (transient receptor potential cation channel subfamily A member 1), which is a validated target, please specify, as TRPA1 possesses ion channel activity and pharmacological relevance[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily A member 2, pseudogene (TRPA2P).